190 related articles for article (PubMed ID: 16782429)
21. Association between pancreatic intraductal papillary mucinous neoplasms and extrapancreatic malignancies.
Marchegiani G; Malleo G; D'Haese JG; Wenzel P; Keskin M; Pugliese L; Borin A; Benning V; Nilsson L; Oruc N; Segersvard R; Friess H; Schmid R; Löhr M; Maisonneuve P; Bassi C; Ceyhan GO; Salvia R; Del Chiaro M
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1162-9. PubMed ID: 25478920
[TBL] [Abstract][Full Text] [Related]
22. Benign intraductal papillary-mucinous neoplasm of the pancreas associated with spontaneous pancreaticogastric and pancreaticoduodenal fistulas.
Jausset F; Delvaux M; Dumitriu D; Bressenot A; Bruot O; Mathias J; Regent D; Laurent V
Digestion; 2010; 82(1):42-6. PubMed ID: 20203511
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients.
Tada M; Kawabe T; Arizumi M; Togawa O; Matsubara S; Yamamoto N; Nakai Y; Sasahira N; Hirano K; Tsujino T; Tateishi K; Isayama H; Toda N; Yoshida H; Omata M
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1265-70. PubMed ID: 16979953
[TBL] [Abstract][Full Text] [Related]
24. Second primary cancer in patients with colorectal cancer after a curative resection.
Noura S; Ohue M; Seki Y; Tanaka K; Motoori M; Kishi K; Miyashiro I; Ohigashi H; Yano M; Ishikawa O; Tsukuma H; Murata K; Kameyama M
Dig Surg; 2009; 26(5):400-5. PubMed ID: 19923828
[TBL] [Abstract][Full Text] [Related]
25. Pylorus-preserving total pancreatectomy for an intraductal papillary-mucinous neoplasm of the pancreas.
Inagaki M; Obara M; Kino S; Goto J; Suzuki S; Ishizaki A; Tanno S; Kohgo Y; Tokusashi Y; Miyokawa N; Kasai S
J Hepatobiliary Pancreat Surg; 2007; 14(3):264-9. PubMed ID: 17520201
[TBL] [Abstract][Full Text] [Related]
26. Acute recurrent pancreatitis curtaining an intraductal papillary mucinous tumor of the pancreas.
Retter J; Dinter D; Bersch C; Singer MV; Löhr M
J Gastrointestin Liver Dis; 2007 Dec; 16(4):445-7. PubMed ID: 18193131
[TBL] [Abstract][Full Text] [Related]
27. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
[TBL] [Abstract][Full Text] [Related]
28. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
Schmidt CM; White PB; Waters JA; Yiannoutsos CT; Cummings OW; Baker M; Howard TJ; Zyromski NJ; Nakeeb A; DeWitt JM; Akisik FM; Sherman S; Pitt HA; Lillemoe KD
Ann Surg; 2007 Oct; 246(4):644-51; discussion 651-4. PubMed ID: 17893501
[TBL] [Abstract][Full Text] [Related]
29. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm.
Tanno S; Nakano Y; Sugiyama Y; Nakamura K; Sasajima J; Koizumi K; Yamazaki M; Nishikawa T; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y
Pancreatology; 2010; 10(2-3):173-8. PubMed ID: 20484955
[TBL] [Abstract][Full Text] [Related]
30. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas.
Bournet B; Kirzin S; Carrère N; Portier G; Otal P; Selves J; Musso C; Suc B; Moreau J; Fourtanier G; Pradère B; Lazorthes F; Escourrou J; Buscail L
J Gastroenterol Hepatol; 2009 Jul; 24(7):1211-7. PubMed ID: 19476563
[TBL] [Abstract][Full Text] [Related]
31. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas.
Wada K; Kozarek RA; Traverso LW
Am J Surg; 2005 May; 189(5):632-6; discussion 637. PubMed ID: 15862510
[TBL] [Abstract][Full Text] [Related]
32. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
33. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: evaluation of predictive factors by logistic regression analysis.
Takeshita K; Kutomi K; Takada K; Haruyama T; Fukushima J; Aida R; Takada T; Furui S
J Comput Assist Tomogr; 2008; 32(2):191-7. PubMed ID: 18379300
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic head resection with segmental duodenectomy: safety and long-term results.
Nakao A; Fernández-Cruz L
Ann Surg; 2007 Dec; 246(6):923-8; discussion 929-31. PubMed ID: 18043093
[TBL] [Abstract][Full Text] [Related]
35. Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm.
Malleo G; Marchegiani G; Borin A; Capelli P; Accordini F; Butturini G; Pederzoli P; Bassi C; Salvia R
Ann Surg; 2015 May; 261(5):984-90. PubMed ID: 25493361
[TBL] [Abstract][Full Text] [Related]
36. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?
Lubezky N; Ben-Haim M; Lahat G; Marmor S; Solar I; Brazowski E; Nackache R; Klausner JM
Surgery; 2012 Jan; 151(1):70-5. PubMed ID: 21975290
[TBL] [Abstract][Full Text] [Related]
37. Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas: an institutional experience.
Yang AD; Melstrom LG; Bentrem DJ; Ujiki MB; Wayne JD; Strouch M; Bell RH; Rao SM; Talamonti MS
Surgery; 2007 Oct; 142(4):529-34; discussion 534-7. PubMed ID: 17950345
[TBL] [Abstract][Full Text] [Related]
38. [Extrapancreatic tumors in intraductal papillary mucinous neoplasm of the pancreas].
Oh SJ; Lee SJ; Lee HY; Paik YH; Lee DK; Lee KS; Chung JB; Yu JS; Yoon DS
Korean J Gastroenterol; 2009 Sep; 54(3):162-6. PubMed ID: 19844152
[TBL] [Abstract][Full Text] [Related]
39. Frequency of intraductal papillary mucinous neoplasm in patients with and without pancreas cancer.
Macari M; Eubig J; Robinson E; Megibow A; Newman E; Babb J; Pachter HL; Hajdu C
Pancreatology; 2010; 10(6):734-41. PubMed ID: 21252588
[TBL] [Abstract][Full Text] [Related]
40. S100P is an early developmental marker of pancreatic carcinogenesis.
Ohuchida K; Mizumoto K; Egami T; Yamaguchi H; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2006 Sep; 12(18):5411-6. PubMed ID: 17000674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
